Pharmaceutical Technology Europe-01-01-2013

Happy New Year! It's the beginning of another year in this digital age where science and technology continue to advance with leaps and bounds. And one can't help but ask, what awaits pharma in 2013?

FDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, overall approaches.

PharmTech speaks to Ray O'Connor from the National Institute for Bioprocessing Research and Training (NIBRT) for an overview of aseptic processing.

Vaccine manufacturing was predicted in 2008 to be on the cusp of a golden era, but instead the industry has experienced cost pressures, high-profile liability cases and production setbacks.

Editor's Picks of Pharmaceutical Science & Technology Innovations

Click the title above to open the Pharmaceutical Technology Europe January 2013 issue in an interactive PDF format.